Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03716726 · ClinicalTrials.gov registry record · NA
Sickle Cell Anemia WE CARE
A NA study of Sickle Cell Disease, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 112
- Enrollment target
- 1
- Study location
NCT03716726 is a NA study of Sickle Cell Disease that has completed, run by Boston Medical Center. The registered enrollment target is 112 participants, below the 292-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03716726, a NA study of Sickle Cell Disease, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
- 1
- Study location
Study Summary
This mixed-methods study aims to understand the implementation of a previously tested, efficacious social determinants of health (SDoH) screening and referral intervention in the outpatient pediatric hematology setting; qualitatively assess possible mechanisms for such interventions on improving child health; and obtain population-specific empirical estimates to plan a large-scale clinical trial.
Conditions Studied
Interventions
- OTHER Standard of care
- BEHAVIORAL WE CARE SDoH Screening Survey
- BEHAVIORAL Family Resource Book
Study Locations (1)
Massachusetts
- Boston Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2021-01-21 |
| Est. Completion | 2023-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03716726
The ClinicalTrials.gov registry entry for NCT03716726 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 292-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (62% lower). The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sickle Cell Disease appearing as the primary indexed condition, and to 3 interventions - of which Standard of care is the first listed.
NCT03716726 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03716726 about?
NCT03716726 is a clinical study titled "Sickle Cell Anemia WE CARE". This mixed-methods study aims to understand the implementation of a previously tested, efficacious social determinants of health (SDoH) screening and referral intervention in the outpatient pediatric hematology setting; qualitatively assess possible mechanisms for such interventions on improving chi...
What is the current status of trial NCT03716726?
This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2021-01-21. Estimated completion is 2023-02-01.
What conditions does trial NCT03716726 study?
This clinical trial studies the following conditions: Sickle Cell Disease.
What interventions are being tested in trial NCT03716726?
The interventions under investigation include: Standard of care (OTHER), WE CARE SDoH Screening Survey (BEHAVIORAL), Family Resource Book (BEHAVIORAL).
Who is sponsoring clinical trial NCT03716726?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03716726 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sickle Cell Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
Exercise in Child Health
RECRUITING · NA
-
Sickle Cell Children's Exercise Study (SuCCESs)
RECRUITING · NA
-
Cutaneous Hydration Assessment in SCD
RECRUITING · NA
-
MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.